Free Content

ASH regularly produces educational webinars, video series, and podcasts that feature presentations by experts in the field, cover current information on how to best diagnose and care for patients, and topical discussion on issues relevant to hematology. This content is free to stream on ASH On Demand.


Description

Wendy Stock, MD, discusses the current tools to measure minimal residual disease in acute lymphoblastic leukemia (ALL), how minimal residual disease impacts treatment decisions for ALL, and more. Dr. Stock presented on the topic at the 2016 ASH Meeting on Hematologic Malignancies in a session titled "How I Treat ALL in First Complete Remission: Role of MRD and Molecular Genetics in Treatment Decisions."

Speakers

  • Wendy Stock, MD

Description

"How to Treat Chronic Lymphocytic Leukemia (CLL)" w/Dr. Richard Furman, Associate Professor at Weill Cornell Medical College with research focus on Chronic Lymphocytic Leukemia (CLL)
Podcasts from the 2016 ASH Meeting on Hematologic Malignancies (MHM) held in Chicago last September. To view recorded sessions from the meeting, please visit ashondemand.org/Meeting/109612279.
To register for the 2017 ASH Meeting on Hematologic Malignancies, visit hematology.org/malignancies

Speakers

  • Dr. Richard Furman

Description

"How to Treat Newly Diagnosed Multiple Myeloma" w/Dr. Sagar Lonial, Chair of the Department of Hematology and Medical Oncology at Winship Cancer Institute of Emory University.
Podcasts from the 2016 ASH Meeting on Hematologic Malignancies (MHM) held in Chicago last September. To view recorded sessions from the meeting, please visit ashondemand.org/Meeting/109612279.
To register for the 2017 ASH Meeting on Hematologic Malignancies, visit hematology.org/malignancies

Speakers

  • Dr. Sagar Lonial

Description

"How Physicians Diagnose Myelodysplastic Syndromes(MDS)" w/ Dr. David Steensma, Senior Physician at the Dana Farber Cancer Institute, and Associate Professor of Medicine at Harvard Medical School.
Podcasts from the 2016 ASH Meeting on Hematologic Malignancies (MHM) held in Chicago last September. To view recorded sessions from the meeting, please visit ashondemand.org/Meeting/109612279.
To register for the 2017 ASH Meeting on Hematologic Malignancies, visit hematology.org/malignancies

Speakers

  • Dr. David Steensma

Description

"How to Treat High-Grade Myelodysplastic Syndromes (MDS)" w/Dr. Hetty Carraway, Medical Oncologist at The Cleveland Clinic.
Podcasts from the 2016 ASH Meeting on Hematologic Malignancies (MHM) held in Chicago last September. To view recorded sessions from the meeting, please visit ashondemand.org/Meeting/109612279.
To register for the 2017 ASH Meeting on Hematologic Malignancies, visit hematology.org/malignancies

Speakers

  • Dr. Hetty Carraway

Description

"Therapies for Acute Lymphoblastic Leukemia (ALL) & How Minimal Residual Disease Effects Treatment" w/Dr. Wendy Stock, Professor of Medicine at the University of Chicago.
Podcasts from the 2016 ASH Meeting on Hematologic Malignancies (MHM) held in Chicago last September. To view recorded sessions from the meeting, please visit ashondemand.org/Meeting/109612279.
To register for the 2017 ASH Meeting on Hematologic Malignancies, visit hematology.org/malignancies

Speakers

  • Dr. Wendy Stock

Description

"The Testing of Novel Small Molecules and Antibody Treatments for CLL" with Dr. Jennifer Brown, Director of the CLL Center at The Dana Farber Cancer Institute.
Podcasts from the 2016 ASH Meeting on Hematologic Malignancies (MHM) held in Chicago last September. To view recorded sessions from the meeting, please visit ashondemand.org/Meeting/109612279.
o register for the 2017 ASH Meeting on Hematologic Malignancies, visit hematology.org/malignancies

Speakers

  • Dr. Jennifer Brown

Description

"Ways to Treat Highly Aggressive Lymphomas" w/Dr. Jonathan Friedberg, Director of the Wilmot Cancer Institute at the University of Rochester.
Podcasts from the 2016 ASH Meeting on Hematologic Malignancies (MHM) held in Chicago last September. To view recorded sessions from the meeting, please visit ashondemand.org/Meeting/109612279.
To register for the 2017 ASH Meeting on Hematologic Malignancies, visit hematology.org/malignancies

Speakers

  • Dr. Jonathan Friedberg

Description

"Different Options for Treating Myelofibrosis Patients" w/Dr. Ruben Mesa, Professor and Chair of the Division of Hematology and Medical Oncology at the Mayo Clinic.
Podcasts from the 2016 ASH Meeting on Hematologic Malignancies (MHM) held in Chicago last September. To view recorded sessions from the meeting, please visit ashondemand.org/Meeting/109612279.
To register for the 2017 ASH Meeting on Hematologic Malignancies, visit hematology.org/malignancies

Speakers

  • Dr. Ruben Mesa

Description

Thinking of attending the 2017 ASH Meeting on Hematologic Malignancies? Join us for the first in a series of special webinar previews of the 2017 meeting. Listen to speakers from the meeting as they preview their presentations, then stay for a special Q&A session to talk directly to meeting organizers and find out why you should join us in Chicago in September 2017!
The ASH Meeting on Hematologic Malignancies includes five core malignant hematology themes: leukemia, lymphoma, myelodysplastic syndromes, myeloproliferative neoplasm, and myeloma. This Focus on Myeloma webinar will feature a discussion with three clinicians in the area of Myeloma regarding how clinical practice has evolved in recent years, as well as discussion of important conclusions from the previous year’s meeting. The doctors will also discuss what to expect in the coming year, with emphasis on how “How I Treat” is a different approach than the classic format of educational and or scientific sessions.
The webinar will include a special Q&A session with meeting organizers for participants to chat about anything related to the meeting or registration.
The next ASH Meeting on Hematologic Malignancies will be held in Chicago, IL, September 8-9, 2017. The program’s “How I Treat” presentations showcase speakers’ evidence-based treatment approaches, identify cutting-edge scientific data that can be translated into new strategies for diagnosis and treatment, and address what to do in cases where there is no data. This meeting is a unique opportunity to join colleagues and top experts in treatment of hematologic malignancies in an intimate, smaller-meeting setting and discuss the latest drug developments and most relevant research findings advancing patient care today. Visit www.hematology.org/malignancies for information related to next year’s meeting!

Speakers

  • Ken Anderson, MD, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute
  • Noopur Raje, MD, Multiple Myeloma Center, Massachusetts General Hospital
  • S. Vincent Rajkumar, MD, Edward W. and Betty Knight Scripps Professor of Medicine, Mayo Clinic
1 of 8
back to top